So, is the PR machine being cranked up again after the recent lull?
Good to see Dr Price on the road and evangelizing the ATL1102 story with the community.
”We look forward to expanding our engagement with US-based DMD community members, clinicians, and industry partners as we progress towards defining the regulatory pathway for ATL1102 in DMD in the US”
Sarepta didn't show up in the recent PPMD conference - they cancelled their appearance after the gene therapy results.
The doors are starting to slide and Wayne's "trading places" thesis is playing out in front of us.
Will ANP become the new hope for the DMD community?
Disclosure: this is a ramp!
Ann: Jett Foundation 4th Annual Rare Disease Day, page-2
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
-0.001(1.30%) |
Mkt cap ! $69.41M | |||
| Open | High | Low | Value | Volume |
| 7.9¢ | 7.9¢ | 7.6¢ | $15.61K | 200K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 110000 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 101042 | 3 |
View Market Depth
| Last trade - 12.51pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.9¢ |
Change
-0.001 ( 1.28 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 7.9¢ | 7.9¢ | 6979 | ||
| Last updated 12.03pm 06/05/2024 ? | |||||
| PER (ASX) Chart |